In agreement with the published data [20,21], the PAH-PASMCs displayed a distinct expression signature with an upregulation of Survivin and a marked diminution of the mitochondrial antioxidant enzyme superoxide dismutase 2 (SOD2) (Figure 2A). The gene discussed is BIRC5; the disease is pulmonary arterial hypertension.